George Robinson invests in Oxford spinouts Adaptimmune (ADAP) & Immunocore (IMCR). ADAP listed on Nasdaq in 2015 and IMCR on the same exchange in early 2021.
25th OTIF investment in Oxford University spinout OrthoSon, which is revolutionising the treatment of back pain.
Christopher Hall joins OIC as Partner, bringing a wealth of legal, corporate finance and early-stage investment experience.
50th OIC investment in Oxford University spinout Oxford Advanced Surfaces, which is transforming how the surface of composite materials are prepared and bonded.
OIC invests in Oxford PV‘s £65m Series D alongside Equinor, Legal & General, Meyer Berger and Xinjiang Goldwind.
PhishAR, a company using AI to target phishing attacks, is the 200th spinout from Oxford University.
First investment made in Oxford University spinout SpyBiotech, which is transforming how vaccines to prevent deadly diseases are developed.
OIC makes its fourth investment in ONI‘s $75m Series B financing led by US investors ARCH Venture Partners and Casdin Capital, and included Section 32, ARTIS Ventures, Vertical Venture Partners, Axon Ventures and Oxford Science Enterprises.